Tung GK - Search Results

1

Myopia, its prevalence, current therapeutic strategy and recent developments: A Review.

Singh H, Singh H, Latief U, Tung GK, Shahtaghi NR, Sahajpal NS, Kaur I, Jain SK. Singh H, et al. Among authors: tung gk. Indian J Ophthalmol. 2022 Aug;70(8):2788-2799. doi: 10.4103/ijo.IJO_2415_21. Indian J Ophthalmol. 2022. PMID: 35918918 Free PMC article. Review.

2

3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation.

Verma H, Narendra G, Raju B, Kumar M, Jain SK, Tung GK, Singh PK, Silakari O. Verma H, et al. Among authors: tung gk. Arch Pharm (Weinheim). 2022 Sep;355(9):e2200108. doi: 10.1002/ardp.202200108. Epub 2022 May 26. Arch Pharm (Weinheim). 2022. PMID: 35618489

3

Preparation and Characterisation of Liposomes of Bergenia Ciliata Extract and Evaluation of their Hepatoprotective Activity.

Latief U, Kaur M, Dar SH, Thakur S, Per TS, Tung GK, Jain SK. Latief U, et al. Among authors: tung gk. J Pharm Sci. 2023 Jan;112(1):328-335. doi: 10.1016/j.xphs.2022.07.013. Epub 2022 Jul 21. J Pharm Sci. 2023. PMID: 35872024

4

Micro RNAs as Emerging Therapeutic Targets in Liver Diseases.

Latief U, Tung GK, Per TS, Kaur M, Thakur S, Singh H, Jain SK. Latief U, et al. Among authors: tung gk. Curr Protein Pept Sci. 2022;23(6):369-383. doi: 10.2174/1389203723666220721122240. Curr Protein Pept Sci. 2022. PMID: 35899959 Review.

5

Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach.

Narendra G, Raju B, Verma H, Kumar M, Jain SK, Tung GK, Thakur S, Kaur R, Kaur S, Sapra B, Singh PK, Silakari O. Narendra G, et al. Among authors: tung gk. Int J Biol Macromol. 2023 Jul 1;242(Pt 1):124749. doi: 10.1016/j.ijbiomac.2023.124749. Epub 2023 May 7. Int J Biol Macromol. 2023. PMID: 37160174

6

Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation.

Narendra G, Raju B, Verma H, Kumar M, Jain SK, Tung GK, Thakur S, Kaur R, Kaur S, Sapra B, Silakari O. Narendra G, et al. Among authors: tung gk. RSC Med Chem. 2023 Nov 30;15(1):309-321. doi: 10.1039/d3md00543g. eCollection 2024 Jan 25. RSC Med Chem. 2023. PMID: 38283216

7

Association of VEGF -2549 I/D and VEGF +936 C/T Polymorphisms with Chronic Kidney Disease in North-West Indian Patients.

Tung GK, Sambyal V, Guleria K. Tung GK, et al. Indian J Nephrol. 2022 Sep-Oct;32(5):445-451. doi: 10.4103/ijn.ijn_420_21. Epub 2022 Jul 16. Indian J Nephrol. 2022. PMID: 36568591 Free PMC article.

8

Baseline and oxidatively damaged DNA in end-stage renal disease patients on varied hemodialysis regimens: a comet assay assessment.

Tung GK, Gandhi G. Tung GK, et al. Mol Cell Biochem. 2024 Feb;479(2):199-211. doi: 10.1007/s11010-023-04720-4. Epub 2023 Apr 1. Mol Cell Biochem. 2024. PMID: 37004640

9

In silico guided designing of optimized benzochalcones derivatives as potent CYP1B1 inhibitors: An integrated in vitro and ONIOM study.

Sharma H, Raju B, Narendra G, Kumar M, Verma H, Sharma B, Tung GK, Kumar Jain S, Brás NF, Silakari O. Sharma H, et al. Among authors: tung gk. J Mol Graph Model. 2023 Mar;119:108390. doi: 10.1016/j.jmgm.2022.108390. Epub 2022 Dec 2. J Mol Graph Model. 2023. PMID: 36502606

10

Genotoxic damage in end-stage renal disease.

Gandhi G, Mehta T, Contractor P, Tung G. Gandhi G, et al. Mutat Res Genet Toxicol Environ Mutagen. 2018 Nov;835:1-10. doi: 10.1016/j.mrgentox.2018.08.005. Epub 2018 Aug 16. Mutat Res Genet Toxicol Environ Mutagen. 2018. PMID: 30249475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page